Amelioration of DSS-induced murine colitis by VSL#3 supplementation is primarily associated with changes in ileal microbiota composition

Gut Microbes

Volumn 5, Issue 4, 2014, Pages 494-503

  Mar, Jordan S ^a   Nagalingam, Nabeetha A ^a   Song, Yuanlin ^a   Onizawa, Michio ^a   Lee, Jae Woo ^a   Lynch, Susan V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

16S rRNA; DSS; Ileum; Microbiome; Microbiota; Probiotic; Stem cells; Ulcerative Colitis; VSL 3

Indexed keywords

DEXTRAN SULFATE; PROBIOTIC AGENT; RNA 16S;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACILLACEAE; BRADYRHIZOBIUM; CECUM; CELL THERAPY; COLON; COMPUTER MODEL; CONTROLLED STUDY; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DIET SUPPLEMENTATION; HISTOLOGY; ILEAL MICROBIOTA; ILEUM; INTESTINE FLORA; LACHNOSPIRACEAE; LACTOBACILLACEAE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PREVOTELLA; STREPTOCOCCUS; ANIMAL; BACTERIUM; BIOTA; C57BL MOUSE; CHEMICALLY INDUCED; CLASSIFICATION; COLITIS; CYTOCHEMISTRY; DIET THERAPY; DRUG EFFECTS; FEMALE; GASTROINTESTINAL TRACT; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; BACTERIA; BIOTA; CECUM; COLITIS; COLON; DEXTRAN SULFATE; DIET THERAPY; FEMALE; GASTROINTESTINAL TRACT; HISTOCYTOCHEMISTRY; ILEUM; MICE, INBRED C57BL; PROBIOTICS; SEVERITY OF ILLNESS INDEX; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84922719336     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.32147     Document Type: Article

References (59)

1. Langholz E. Current trends in inflammatory bowel disease: the natural history. Therap Adv Gastroenterol 2010; 3:77-86 PMID:21180592; http://dx.doi.org/10.1177/1756283X10361304
2. Packey CD, Sartor RB. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med 2008; 263:597-606 PMID:18479259; http://dx.doi. org/10.1111/j.1365-2796.2008.01962.x
3. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139:485-98 PMID:19836068; http://dx.doi.org/10.1016/j. cell.2009.09.033
4. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331:337-41 PMID:21205640; http://dx.doi. org/10.1126/science.1198469
5. von Schillde MA, Hörmannsperger G, Weiher M, Alpert CA, Hahne H, Bäuerl C, van Huynegem K, Steidler L, Hrncir T, Pérez-Martínez G, et al. Lactocepin secreted by Lactobacillus exerts antiinflammatory effects by selectively degrading proinflammatory chemokines. Cell Host Microbe 2012; 11:387-96 PMID:22520466; http://dx.doi. org/10.1016/j.chom.2012.02.006
6. Yan F, Cao H, Cover TL, Washington MK, Shi Y, Liu L, Chaturvedi R, Peek RM Jr., Wilson KT, Polk DB. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest 2011; 121:2242-53 PMID:21606592; http://dx.doi.org/10.1172/JCI44031
7. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 2010; 107:12204-9 PMID:20566854; http:// dx.doi.org/10.1073/pnas.0909122107
8. Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn’s disease and ulcerative colitis patients. J Med Microbiol 2006; 55:1141-9 PMID:16849736; http://dx.doi. org/10.1099/jmm.0.46498-0
9. Uronis JM, Arthur JC, Keku T, Fodor A, Carroll IM, Cruz ML, Appleyard CB, Jobin C. Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis. Inflamm Bowel Dis 2011; 17:289-97 PMID:20564535; http://dx.doi.org/10.1002/ibd.21366
10. Nagalingam NA, Kao JY, Young VB. Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis. Inflamm Bowel Dis 2011; 17:917-26 PMID:21391286; http://dx.doi.org/10.1002/ibd.21462
11. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inf lammatory bowel diseases. Proc Natl Acad Sci U S A 2007; 104:13780-5 PMID:17699621; http://dx.doi.org/10.1073/ pnas.0706625104
12. Kabeerdoss J, Sankaran V, Pugazhendhi S, Ramakrishna BS. Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inf lammatory bowel disease: a case-control study in India. BMC Gastroenterol 2013; 13:20 PMID:23351032; http://dx.doi. org/10.1186/1471-230X-13-20
13. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, Doré J. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inf lamm Bowel Dis 2009; 15:1183-9 PMID:19235886; http://dx.doi. org/10.1002/ibd.20903
14. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, Timmis KN, Schreiber S. Reduction in diversity of the colonic mucosa associated bacterial microf lora in patients with active inf lammatory bowel disease. Gut 2004; 53:685-93 PMID:15082587; http://dx.doi.org/10.1136/ gut.2003.025403
15. Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, Rayment N, Brostoff J, Parkhill J, Dougan G, Petrovska L. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inf lamed and non-inf lamed regions of the intestine in inf lammatory bowel disease. BMC Microbiol 2011; 11:7 PMID:21219646; http://dx.doi. org/10.1186/1471-2180-11-7
16. Kumari R, Ahuja V, Paul J. Fluctuations in butyrateproducing bacteria in ulcerative colitis patients of North India. World J Gastroenterol 2013; 19:3404-14 PMID:23801832; http://dx.doi.org/10.3748/ wjg.v19.i22.3404
17. Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 2009; 294:1-8 PMID:19222573; http://dx.doi. org/10.1111/j.1574-6968.2009.01514.x
18. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341:569-73 PMID:23828891; http://dx.doi. org/10.1126/science.1241165
19. Segain JP, Raingeard de la Blétière D, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, Bonnet C, Blottière HM, Galmiche JP. Butyrate inhibits inf lammatory responses through NFkappaB inhibition: implications for Crohn’s disease. Gut 2000; 47:397-403 PMID:10940278; http://dx.doi. org/10.1136/gut.47.3.397
20. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008; 105:16731-6 PMID:18936492; http:// dx.doi.org/10.1073/pnas.0804812105
21. Okamoto T, Sasaki M, Tsujikawa T, Fujiyama Y, Bamba T, Kusunoki M. Preventive efficacy of butyrate enemas and oral administration of Clostridium butyricum M588 in dextran sodium sulfate-induced colitis in rats. J Gastroenterol 2000; 35:341-6 PMID:10832668; http://dx.doi.org/10.1007/ s005350050358
22. Hudcovic T, Kolinska J, Klepetar J, Stepankova R, Rezanka T, Srutkova D, Schwarzer M, Erban V, Du Z, Wells JM, et al. Protective effect of Clostridium tyrobutyricum in acute dextran sodium sulphateinduced colitis: differential regulation of tumour necrosis factor-α and interleukin-18 in BALB/c and severe combined immunodeficiency mice. Clin Exp Immunol 2012; 167:356-65 PMID:22236013; http://dx.doi.org/10.1111/j.1365-2249.2011.04498.x
23. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011; 474:298-306 PMID:21677746; http://dx.doi. org/10.1038/nature10208
24. Harrison OJ, Maloy KJ. Innate immune activation in intestinal homeostasis. J Innate Immun 2011; 3:585-93 PMID:21912101; http://dx.doi. org/10.1159/000330913
25. Brandtzaeg P, Carlsen HS, Halstensen TS. The B-cell system in inflammatory bowel disease. Adv Exp Med Biol 2006; 579:149-67 PMID:16620017; http:// dx.doi.org/10.1007/0-387-33778-4_10
26. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999; 354:635-9 PMID:10466665; http://dx.doi.org/10.1016/ S0140-6736(98)06343-0
27. Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, Sartor RB. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 2005; 100:1539-46 PMID:15984978; http://dx.doi. org/10.1111/j.1572-0241.2005.41794.x
28. Haller D, Antoine JM, Bengmark S, Enck P, Rijkers GT, Lenoir-Wijnkoop I. Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome. J Nutr 2010; 140:690S-7S PMID:20107148; http://dx.doi. org/10.3945/jn.109.113746
29. Yui S, Nakamura T, Sato T, Nemoto Y, Mizutani T, Zheng X, Ichinose S, Nagaishi T, Okamoto R, Tsuchiya K, et al. Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5+ stem cell. Nat Med 2012; 18:618-23 PMID:22406745; http:// dx.doi.org/10.1038/nm.2695
30. He XW, He XS, Lian L, Wu XJ, Lan P. Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice. Dig Dis Sci 2012; 57:3136-44 PMID:22752635; http:// dx.doi.org/10.1007/s10620-012-2290-5
31. Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 2013; 31:814-21 PMID:23975157; http://dx.doi. org/10.1038/nbt.2676
32. Berry D, Schwab C, Milinovich G, Reichert J, Ben Mahfoudh K, Decker T, Engel M, Hai B, Hainzl E, Heider S, et al. Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis. ISME J 2012; 6:2091-106 PMID:22572638; http://dx.doi.org/10.1038/ ismej.2012.39
33. Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal hostmicrobial interface. Proc Natl Acad Sci U S A 2008; 105:20858-63 PMID:19075245; http://dx.doi. org/10.1073/pnas.0808723105
34. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 2002; 99:15451-5 PMID:12432102; http://dx.doi.org/10.1073/pnas.202604299
35. Bansal T, Alaniz RC, Wood TK, Jayaraman A. The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proc Natl Acad Sci U S A 2010; 107:228-33 PMID:19966295; http://dx.doi. org/10.1073/pnas.0906112107
36. Medeiros MR, Prado LA, Fernandes VC, Figueiredo SS, Coppede J, Martins J, Fiori GM, Martinez-Rossi NM, Beleboni RO, Contini SH, et al. Antimicrobial activities of indole alkaloids from Tabernaemontana catharinensis. Nat Prod Commun 2011; 6:193-6 PMID:21425672
37. Tamaoki J, Kadota J, Takizawa H. Clinical implications of the immunomodulatory effects of macrolides. Am J Med 2004; 117(Suppl 9A):5S-11S PMID:15586558
38. Bartosh TJ, Ylöstalo JH, Mohammadipoor A, Bazhanov N, Coble K, Claypool K, Lee RH, Choi H, Prockop DJ. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S A 2010; 107:13724-9 PMID:20643923; http://dx.doi.org/10.1073/pnas.1008117107
39. Kruis W, Schütz E, Fric P, Fixa B, Judmaier G, Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997; 11:853-8 PMID:9354192; http://dx.doi. org/10.1046/j.1365-2036.1997.00225.x
40. Kruis W, Fric P, Pokrotnieks J, Lukás M, Fixa B, Kascák M, Kamm MA, Weismueller J, Beglinger C, Stolte M, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004; 53:1617-23 PMID:15479682; http://dx.doi. org/10.1136/gut.2003.037747
41. Möndel M, Schroeder BO, Zimmermann K, Huber H, Nuding S, Beisner J, Fellermann K, Stange EF, Wehkamp J. Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol 2009; 2:166-72 PMID:19129752; http://dx.doi. org/10.1038/mi.2008.77
42. Collins MD, Lawson PA, Willems A, Cordoba JJ, Fernandez-Garayzabal J, Garcia P, Cai J, Hippe H, Farrow JA. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int J Syst Bacteriol 1994; 44:812-26 PMID:7981107; http://dx.doi. org/10.1099/00207713-44-4-812
43. Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, Shen B, Schaeffeler E, Schwab M, Linzmeier R, et al. Reduced Paneth cell alpha-defensins in ileal Crohn’s disease. Proc Natl Acad Sci U S A 2005; 102:18129-34 PMID:16330776; http://dx.doi.org/10.1073/ pnas.0505256102
44. Garner CD, Antonopoulos DA, Wagner B, Duhamel GE, Keresztes I, Ross DA, Young VB, Altier C. Perturbation of the small intestine microbial ecology by streptomycin alters pathology in a Salmonella enterica serovar typhimurium murine model of infection. Infect Immun 2009; 77:2691-702 PMID:19433544; http://dx.doi.org/10.1128/ IAI.01570-08
45. Meisch JP, Nishimura M, Vogel RM, Sung HC, Bednarchik BA, Ghosh SK, Fu P, McCormick T, Weinberg A, Levine AD. Human β-defensin 3 peptide is increased and redistributed in Crohn’s ileitis. Inf lamm Bowel Dis 2013; 19:942-53 PMID:23511030; http://dx.doi.org/10.1097/ MIB.0b013e318280b11a
46. Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Carbo A, Shaykhutdinov R, Jobin C, Arthur JC, Corl BA, Vogel H, et al. Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis. PLoS One 2012; 7:e31238 PMID:22363592; http://dx.doi.org/10.1371/journal.pone.0031238
47. Pagnini C, Saeed R, Bamias G, Arseneau KO, Pizarro TT, Cominelli F. Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Natl Acad Sci U S A 2010; 107:454-9 PMID:20018654; http://dx.doi.org/10.1073/ pnas.0910307107
48. Zhang Q, Shi S, Liu Y, Uyanne J, Shi Y, Shi S, Le AD. Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inf lammation-related tissue destruction in experimental colitis. J Immunol 2009; 183:7787-98 PMID:19923445; http://dx.doi. org/10.4049/jimmunol.0902318
49. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, Brigham KL. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005; 33:145-52 PMID:15891110; http://dx.doi.org/10.1165/ rcmb.2004-0330OC
50. Matters GL, Harms JF, McGovern C, Fitzpatrick L, Parikh A, Nilo N, Smith JP. The opioid antagonist naltrexone improves murine inflammatory bowel disease. J Immunotoxicol 2008; 5:179-87 PMID:18569389; http://dx.doi.org/10.1080/15476910802131469
51. Ishikura T, Kanai T, Uraushihara K, Iiyama R, Makita S, Totsuka T, Yamazaki M, Sawada T, Nakamura T, Miyata T, et al. Interleukin-18 overproduction exacerbates the development of colitis with markedly infiltrated macrophages in interleukin-18 transgenic mice. J Gastroenterol Hepatol 2003; 18:960-9 PMID:12859727; http://dx.doi. org/10.1046/j.1440-1746.2003.03097.x
52. Roediger FC, Slusher NA, Allgaier S, Cox MJ, Pletcher SD, Goldberg AN, Lynch SV. Nucleic acid extraction efficiency and bacterial recovery from maxillary sinus mucosal samples obtained by brushing or biopsy. Am J Rhinol Allergy 2010; 24:263-5 PMID:20819463; http://dx.doi.org/10.2500/ajra.2010.24.3472
53. Cox MJ, Allgaier M, Taylor B, Baek MS, Huang YJ, Daly RA, Karaoz U, Andersen GL, Brown R, Fujimura KE, et al. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One 2010; 5:e11044 PMID:20585638; http://dx.doi. org/10.1371/journal.pone.0011044
54. Hazen TC, Dubinsky EA, DeSantis TZ, Andersen GL, Piceno YM, Singh N, Jansson JK, Probst A, Borglin SE, Fortney JL, et al. Deep-sea oil plume enriches indigenous oil-degrading bacteria. Science 2010; 330:204-8 PMID:20736401; http://dx.doi. org/10.1126/science.1195979
55. Cox MJ, Huang YJ, Fujimura KE, Liu JT, McKean M, Boushey HA, Segal MR, Brodie EL, Cabana MD, Lynch SV. Lactobacillus casei abundance is associated with profound shifts in the infant gut microbiome. PLoS One 2010; 5:e8745 PMID:20090909; http:// dx.doi.org/10.1371/journal.pone.0008745
56. Brodie EL, Desantis TZ, Joyner DC, Baek SM, Larsen JT, Andersen GL, Hazen TC, Richardson PM, Herman DJ, Tokunaga TK, et al. Application of a high-density oligonucleotide microarray approach to study bacterial population dynamics during uranium reduction and reoxidation. Appl Environ Microbiol 2006; 72:6288-98 PMID:16957256; http://dx.doi. org/10.1128/AEM.00246-06
57. Pielou EC. The measurement of diversity in different types of biological samples. J Theor Biol 1966; 13:131-44; http://dx.doi.org/10.1016/0022-5193(66)90013-0
58. Fujimura KE, Johnson CC, Ownby DR, Cox MJ, Brodie EL, Havstad SL, Zoratti EM, Woodcroft KJ, Bobbitt KR, Wegienka G, et al. Man’s best friend? The effect of pet ownership on house dust microbial communities. J Allergy Clin Immunol 2010; 126:410-2, e1-3 PMID:20633927; http://dx.doi.org/10.1016/j. jaci.2010.05.042
59. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological) 1995; 57:6:289-300.